ArticleWorld journal of microbiology & biotechnology2025
Sustainable antifungal potential of ZnO and MoS
Article in World journal of microbiology & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Biogenic synthesis of bioactive zinc nanoparticles from cyanobacterial Nostoc sp. MK-7 for biomedical applications.Discover nano · 2026Article
- Endophytic nanotechnology as a dual-action approach against agricultural and clinical fungal pathogens.Archives of microbiology · 2026Review
- MoSInternational journal of nanomedicine · 2025Article
- Eco-friendly control of fusarium wilt in tomato: molecular docking and functional analysis of ZnO nanoparticles and biostimulants.Frontiers in plant science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study explores the antifungal potential of zinc oxide (ZnO) and molybdenum disulfide (MoS₂) nanoparticles (NPs) against Fusarium oxysporum and Fusarium graminearum, two major fungal pathogens threatening wheat production and grass pastures. Three sizes of ZnO NPs (30 nm, 200 nm, and 20 μm) and MoS₂ NPs (90 nm) were synthesized and characterized using atomic force microscopy (AFM), scanning electron microscopy (SEM), dynamic light scattering (DLS), X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), Raman spectroscopy, ultraviolet-visible (UV-Vis) spectroscopy, and Brunauer-Emmett-Teller (BET) analyses. Antifungal assays revealed that smaller ZnO NPs (30 nm) exhibited superior antifungal activity due to their high surface-to-volume ratio, achieving up to 79% inhibition of F. oxysporum, while MoS₂ NPs effectively inhibited F. graminearum growth by inducing oxidative stress and cellular damage, with a maximum inhibition rate of 83% (p < 0.05). The combination of ZnO and MoS₂ NPs demonstrated synergistic antifungal effects, as confirmed by light microscopy, which showed that ZnO NPs disrupted fungal cell wall integrity while MoS₂ NPs triggered oxidative stress and intracellular vacuolization. Greenhouse trials further validated the effectiveness of MoS₂ NPs in reducing Fusarium head blight (FHB) severity in wheat, underscoring their potential for sustainable wheat protection, with disease severity reduced by up to 35.8%. These findings highlight ZnO and MoS₂ NPs as promising eco-friendly alternatives to conventional fungicides, though further research is needed to optimize field applications, assess environmental impact, and integrate these NPs into comprehensive plant disease management strategies.
Indexed as
Identifiers
40804182What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.